Skip to content
value.today

BioLogiQ, Inc.

🇺🇸 Idaho Falls, Idaho, USAManufacturingFounded 2011
Total raised
$14 M
4 rounds on record
Latest round
$2 M
Dec 2017
First round on record
Apr 2011
Today
Private
No later event on record

Funding rounds

4 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of BioLogiQ, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Dec 2017$2 MNo. 4$2 to $10 million

BioLogiQ, Inc.: Raise no. 4, Dec 2017

Investors in this round

19 investors had bought by the notice of Apr 20, 2018: 19 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$55,706
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Bradford LaPray · Executive Officer, Director · Director and President
  • Grantly Payne · Executive Officer, Director · Director and Secretary
  • Ken Simpson · Executive Officer, Director · Director and Treasurer
  • David Blue · Director
  • Mark Weight · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • ViewTrade Securities, Inc. (CRD 46987) · Boca Raton, FloridaSold in AZ, CO, CT, FL, GA, IA, ID, KS, MN, TX, UT, VA, WI

Signed by Bradford LaPray, President. Source: SEC Form D and 1 amendment, newest notice filed Apr 20, 2018. Read the notice at the SEC.

equitySEC
Dec 2016$4 MNo. 3$2 to $10 million

BioLogiQ, Inc.: Raise no. 3, Dec 2016

Investors in this round

46 investors had bought by the notice of Feb 14, 2018: 46 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $4 M offered
Smallest investment taken
no minimum stated
What was sold
equity, debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$520,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Bradford LaPray · Executive Officer, Director · Director and President
  • Grantly Payne · Executive Officer, Director · Director and Secretary
  • Ken Simpson · Executive Officer, Director · Director and Treasurer
  • David Blue · Director
  • Mark Weight · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • ViewTrade Securities, Inc. (CRD 46987) · Boca Raton, FloridaSold in AZ, CA, CO, FL, GA, ID, MN, ND, NJ, OK, TX, UT, VA, WI

Signed by Bradford LaPray, President. Source: SEC Form D, newest notice filed Feb 14, 2018. Read the notice at the SEC.

equity, debt, optionsSEC
Jan 2013$5 MNo. 2$2 to $10 million

BioLogiQ, Inc.: Raise no. 2, Jan 2013

Investors in this round

30 investors had bought by the notice of Feb 6, 2015: 30 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $6 M offered; $1 M still to sell
Smallest investment taken
$25,000
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Bradford LaPray · Executive Officer, Director · Director and President
  • Grantly Payne · Executive Officer, Director · Director and Secretary
  • Ken Simpson · Executive Officer, Director · Director and Treasurer
  • Brad Gardner · Director
  • Ron Tanner · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Bradford LaPray, President. Source: SEC Form D and 1 amendment, newest notice filed Feb 6, 2015. Read the notice at the SEC.

equitySEC
Apr 2011$3 MNo. 1$2 to $10 million

BioLogiQ, Inc.: Raise no. 1, Apr 2011

Investors in this round

1 investor had bought by the notice of May 3, 2011: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $3 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Bradford LaPray · Executive Officer, Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Common stock was issued in connection with the formation of the company in exchange for certain assets.”

Signed by Bradford LaPray, President. Source: SEC Form D, newest notice filed May 3, 2011. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • BioLogiQ, Inc. chose not to state its revenue in its newest notice of a funding round (Apr 2018).

    SEC Form D · Apr 2018

  • The industry group it chose in its notices: Manufacturing.

    SEC Form D · Apr 2018

That is all the official record says: BioLogiQ, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of BioLogiQ, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 46 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by BioLogiQ, Inc.
NameRoleNamed in
Bradford LaPrayDirector and PresidentApr 2018
Grantly PayneDirector and SecretaryApr 2018
Ken SimpsonDirector and TreasurerApr 2018
Bradford LaPrayDirector and PresidentApr 2018
David BlueDirectorApr 2018
Grantly PayneDirector and SecretaryApr 2018
Ken SimpsonDirector and TreasurerApr 2018
Mark WeightDirectorApr 2018
Brad GardnerDirectorFeb 2015
Ron TannerDirectorFeb 2015